Skip to main content

Table 2 Three-years survival rates of univariate analysis according to the prognostic factors

From: Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University

 

LRFFS

DMFS

PFS

OS

%

P

%

P

%

P

%

P

FIGO stage

 

0.003

 

0.26

 

0.01

 

0.03

  ≤ IIA

100

 

100

 

100

 

100

 

 IIB

95.0

 

75.9

 

75.9

 

88.1

 

 III

71.3

 

65.0

 

46.0

 

52.6

 

 IV

50.0

 

100

 

50.0

 

100

 

Node metastasis

 

0.42

 

0.15

 

0.14

 

0.09

 Negative

95.2

 

83.3

 

79.2

 

91.7

 

 Positive

79.2

 

69.7

 

57.8

 

65.9

 

Parametrial invasion

 

0.95

 

0.42

 

0.60

 

0.84

 Positive

92.1

 

71.7

 

68.2

 

73.5

 

 Negative

75.0

 

90.9

 

68.1

 

88.9

 

Tumor size

 

0.94

 

0.19

 

0.08

 

0.11

  ≤ 5 cm

90.0

 

80.6

 

71.7

 

79.2

 

  > 5 cm

84.1

 

68.0

 

61.0

 

56.8

 

Initial tumor volume

 

0.39

 

0.76

 

0.32

 

0.53

  < 65 cm3

86.5

 

75.7

 

67.3

 

62.4

 

  ≥ 65 cm3

88.4

 

77.3

 

67.7

 

63.7

 

HR-CTV

 

0.18

 

0.39

 

0.06

 

0.12

  ≤ 30 cm3

95.2

 

81.7

 

81.7

 

84.6

 

  > 30 cm3

75.9

 

68.8

 

49.6

 

70.0

 

Chemothrapy

 

0.34

 

0.77

 

0.64

 

0.82

  ≤ 4 course

74.3

 

71.1

 

49.5

 

87.5

 

  ≥ 5 course

94.4

 

78.2

 

76.2

 

73.9

 

D90 (EQD2)

 

0.01

 

0.95

 

0.23

 

0.17

  ≤ 90 Gy

65.0

 

67.7

 

41.4

 

72.9

 

  > 90 Gy

100

 

78.6

 

78.6

 

80.2

 
  1. LRFFS loco-regional failure-free survival, PFS progression-free survival, DMSF distant metastasis-free survival, OS overall survival, FIGO Fédération Internationale de Gynécologie et d’Obstétrique, HR-CTV High risk clinical target volume